New ‘Self-Amplifying’ RNA-Based Vaccine: Progress or Possible Problems?
This month, the approval of an RNA-based vaccine for COVID-19 took another step forward with the endorsement last week by Japanese ...
Read moreDetails
Impakter keeps you informed through its ESG news platform and empowers your business through the Impakter Index.
To assess and improve your company’s ESG performance, explore Klimado’s ESG dashboard and assessment tools at www.klimado.com.
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com